机译:人巨细胞病毒(HCMV)特异性T细胞,但未中和或未中和对糖蛋白复合物GB,GHGLGO和PUL128L的反应与固体器官移植受体中的高HCMV病毒载荷再激活的保护相关
Experimental Research Laboratories Transplantology and Biotechnology Area Fondazione IRCCS;
Experimental Research Laboratories Transplantology and Biotechnology Area Fondazione IRCCS;
Experimental Research Laboratories Transplantology and Biotechnology Area Fondazione IRCCS;
Experimental Research Laboratories Transplantology and Biotechnology Area Fondazione IRCCS;
Nephrology Dialysis and Transplantation UnitFondazione IRCCS Policlinico San MatteoPavia Italy;
Institute for Research in Biomedicine Università della Svizzera ItalianaBellinzona Switzerland;
Experimental Research Laboratories Transplantology and Biotechnology Area Fondazione IRCCS;
Experimental Research Laboratories Transplantology and Biotechnology Area Fondazione IRCCS;
antibody response; high viral load (HVL); human cytomegalovirus (HCMV); low viral load (LVL); solid‐organ transplant recipients (SOTR); T‐cell response;
机译:人巨细胞病毒(HCMV)特异性T细胞,但未中和或未中和对糖蛋白复合物GB,GHGLGO和PUL128L的反应与固体器官移植受体中的高HCMV病毒载荷再激活的保护相关
机译:裸DNA免疫诱导人巨细胞病毒(HCMV)-糖蛋白B(gB)特异性中和抗体和磷蛋白65(pp65)特异性细胞毒性T淋巴细胞反应
机译:对HCMV末端器官疾病艾滋病患者的人巨细胞病毒(HCMV)糖蛋白酶B(GB)的抗体反应。
机译:人巨细胞病毒糖蛋白酶O(GO)表达对GH / GL复合物组装的影响及其多态性对细胞和细胞对细胞的影响,以及抗体中和的影响
机译:人类巨细胞病毒(HCMV)特异的CD4 +和CD8 + T细胞均是预防血清阳性固态器官移植受者HCMV疾病所必需的
机译:人巨细胞病毒(Hcmv)糖蛋白B(Gb)在具有活跃HCMV感染的造血干细胞移植受者中的基因分型:gB基因型对患者结果的影响